Aldosterone promotes calcification of vascular smooth muscle cells in mice through the AIF-1/Wnt/β-catenin signaling pathway
International Urology and Nephrology · 2024
DOI: 10.1007/s11255-024-04213-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Urology and Nephrology, 2024. Verfasst von Xin Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, Heilongjiang, People's Republic of China. Hauptthemen laut MEDLINE: Wnt Signaling Pathway, Muscle, Smooth, Vascular, Aldosterone, Vascular Calcification. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Innovation Fund of Harbin Medical University, Special funding for scientific research projects of The Fourth Affiliated Hospital of Harbin Medical University.
Abstract (Originalsprache)
OBJECTIVE: This study aimed to investigate the impact of aldosterone on calcification in murine vascular smooth muscle cells (VSMCs) via the allograft inflammatory factor-1 (AIF-1)/Wnt/β-catenin signaling pathway. METHODS: Mouse VSMCs were cultured in vitro, and calcification was induced by treatment with 100 nM aldosterone. The level of calcification in mouse VSMCs was evaluated using colorimetric assays to assess ALP activity and qRT-PCR to identify the expression of calcification-related markers, such as Runx2, α-SMA, OCN, and ALP mRNA. Western blot analysis was performed to determine the protein expression levels associated with the Wnt/β-catenin pathway (LRP6, p-LRP6, GSK3β, p-GSK3β, β-catenin) and AIF-1. Plasmid transfection techniques were utilized to either knock down or overexpress AIF-1, and the subsequent alterations in these markers were observed. RESULTS: (1) Compared to the control group, the aldosterone treatment group with exhibited a significant increase in ALP. Concurrently, Runx2, OCN, and ALP mRNA levels increased, as did LRP6, p-LRP6, GSK3β, p-GSK3β, β-catenin, and AIF-1 protein levels. Additionally, a significant decrease in the expression of α-SMA mRNA was observed (P < 0.05). (2) The aldosterone + oe-AIF-1 group showed significant increases in ALP activity compared to the aldosterone + oe-NC group, whereas the aldosterone + sh-AIF-1 group showed significant decreases (P < 0.05). (3) The aldosterone + oe-AIF-1 group exhibited significantly upregulated expression of AIF-1, p-LRP6/LRP6, p-GSK3β/GSK3β, and β-catenin proteins relative to the aldosterone + oe-NC group (P < 0.05). This was concurrent with increased mRNA expression of Runx2, OCN, and ALP, and decreased α-SMA mRNA expression (P < 0.05). CONCLUSION: Aldosterone affects the calcification process in mouse VSMCs, and the activation of the AIF-1/Wnt/β-catenin signaling pathway is the mechanism behind its action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, Heilongjiang, People's Republic of China.
- Department of Nephrology, Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, Heilongjiang, People's Republic of China. 842782@hrbmu.edu.cn.
Förderung
- Innovation Fund of Harbin Medical University
- Special funding for scientific research projects of The Fourth Affiliated Hospital of Harbin Medical University
Zitieren
APA
Li, X., Zhao, Y., & Jiang, G. (2024). Aldosterone promotes calcification of vascular smooth muscle cells in mice through the AIF-1/Wnt/β-catenin signaling pathway. International Urology and Nephrology. https://doi.org/10.1007/s11255-024-04213-3
Vancouver
Li X, Zhao Y, Jiang G. Aldosterone promotes calcification of vascular smooth muscle cells in mice through the AIF-1/Wnt/β-catenin signaling pathway. International Urology and Nephrology. 2024. doi:10.1007/s11255-024-04213-3
BibTeX
@article{Li2024,
author = {Li, Xin and Zhao, Yingzi and Jiang, Guotao},
title = {Aldosterone promotes calcification of vascular smooth muscle cells in mice through the AIF-1/Wnt/β-catenin signaling pathway},
journal = {International Urology and Nephrology},
year = {2024},
doi = {10.1007/s11255-024-04213-3}
}
EUVIMED